Skip to main content
. 2019 Nov 27;24(3):567–576. doi: 10.1007/s10029-019-02089-2

Table 1.

Patient and procedure related influencing factors on the outcome

Sex p
Male Female
n % n %
Procedure
 Laparoscopic-POM 3139 27.50 3222 28.07  < 0.001
 Open suture 1105 9.68 1557 13.56
 Open IPOM 1692 14.82 1504 13.10
 Open Onlay 622 5.45 676 5.89
 Open Sublay 4857 42.55 4521 39.38
ASA-score
 I 1267 11.10 1336 11.64  < 0.001
 II 6333 55.48 6637 57.81
 III/IV 3815 33.42 3507 30.55
EHS-classification (width)
 W1 (< 4 cm) 4132 36.20 4483 39.05  < 0.001
 W2 (> = 4 - 10 cm) 5245 45.95 5274 45.94
 W3 (> 10 cm) 2038 17.85 1723 15.01
EHS-classification (defect localisation)
 Lateral 1855 16.25 2112 18.40  < .001
 Medial 8589 75.24 8461 73.70
 Combined 971 8.51 907 7.90
Preoperative pain
 Yes 5827 51.05 7261 63.25  < .001
 No 4615 40.43 3244 28.26
 Unknown 973 8.52 975 8.49
Drainage
 Yes 6288 55.09 6196 53.97 0.091
 No 5127 44.91 5284 46.03
Risk factors
Total
 Yes 5078 44.49 4304 37.49  < .001
 No 6337 55.51 7176 62.51
COPD
 Yes 1147 10.05 1199 10.44 0.323
 No 10,268 89.95 10,281 89.56
Diabetes
 Yes 1427 12.50 1565 13.63 0.011
 No 9988 87.50 9915 86.37
Aortic aneurism
 Yes 306 2.68 64 0.56  < .001
 No 11,109 97.32 11,416 99.44
Immunosuppression
 Yes 216 1.89 190 1.66 0.174
 No 11,199 98.11 11,290 98.34
Corticoids
 Yes 168 1.47 221 1.93 0.008
 No 11,247 98.53 11,259 98.07
Smoking
 Yes 1628 14.26 1119 9.75  < .001
 No 9787 85.74 10,361 90.25
Coagulopathy
 Yes 289 2.53 186 1.62  < .001
 No 11,126 97.47 11,294 98.38
Antiplatelet medication
 Yes 1688 14.79 1041 9.07  < .001
 No 9727 85.21 10,439 90.93
Anticoagulation therapy
 Yes 410 3.59 302 2.63  < .001
 No 11,005 96.41 11,178 97.37